Swetha Anandhan
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 10, 2025
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.Jielin Liu, Shelley Herbrich, Sreyashi Basu
|Jul 10, 2024
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer.Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami
|Aug 31, 2023
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade.Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh
|Jun 13, 2022
Myeloid cell-targeted therapies for solid tumours.Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri
|Apr 03, 2021
The Next Decade of Immune Checkpoint Therapy.Padmanee Sharma, Bilal A Siddiqui, Swetha Anandhan
|Jun 20, 2020
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC.Sangeeta Goswami, Yulong Chen, Swetha Anandhan
Pageof 1
Frequent Collaborators
5 joint publications
Padmanee Sharma
4 joint publications
Sreyashi Basu
3 joint publications
Sangeeta Goswami
2 joint publications
Shalini Singh Yadav
2 joint publications
James P Allison
2 joint publications
Sonali Jindal
1 joint publications
Jorge M Blando
1 joint publications
Abdel Saci
1 joint publications
Bilal A Siddiqui
1 joint publications
Frederick F Lang
